National Institute on Drug Abuse; Notice of Closed Meetings, 13461 [2017-04808]
Download as PDF
Federal Register / Vol. 82, No. 47 / Monday, March 13, 2017 / Notices
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Tracy A. Shahan, Ph.D.,
MBA, Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, Room #3F31, National Institutes of
Health/NIAID, 5601 Fishers Lane, MSC
79823, Bethesda, MD 20892–9823, (240) 669–
5030, tshahan@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: March 7, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–04809 Filed 3–10–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
mstockstill on DSK3G9T082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Nicotinic Immune Modulation in the
Presence of HIV–1 Infection (R01).
Date: March 22, 2017.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Shang-Yi Anne Tsai,
Ph.D., Scientific Review Officer, Office of
Extramural Policy and Review, Division of
Extramural Research, National Institute on
Drug Abuse, NIH, DHHS, 6001 Executive
Boulevard, Room 4228, MSC 9550, Bethesda,
MD 20892, 301–827–5842, shangyi.tsai@
nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; HIV,
HCV and Related Comorbidities in Rural
Communities Affected by Opioid Injection
VerDate Sep<11>2014
17:49 Mar 10, 2017
Jkt 241001
Drug Epidemics in the United States:
Building Systems for Prevention, Treatment
and Control (UG3/UH3).
Date: March 24, 2017.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: Courtyard by Marriott Chevy Chase,
5520 Wisconsin Avenue, Chevy Chase, MD
20815.
Contact Person: Hiromi Ono, Ph.D.,
Scientific Review Officer, Office of
Extramural Policy and Review, National
Institute on Drug Abuse, National Institutes
of Health, DHHS, 6001 Executive Boulevard,
Room 4238, MSC 9550, Bethesda, MD 20892,
301–827–5820, hiromi.ono@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Hepatitis C Virus (HCV) Advanced Molecular
Detection in Support of Systems for
Prevention, Treatment and Control of HIV,
HCV and Related Comorbidities in Rural
Communities Affected by Opioid Injection
Drug Epidemics in the Unite.
Date: March 24, 2017.
Time: 12:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: Courtyard by Marriott Chevy Chase,
5520 Wisconsin Avenue, Chevy Chase, MD
20815.
Contact Person: Hiromi Ono, Ph.D.,
Scientific Review Officer, Office of
Extramural Policy and Review, National
Institute on Drug Abuse, National Institutes
of Health, DHHS, 6001 Executive Boulevard,
Room 4238, MSC 9550, Bethesda, MD 20892,
301–827–5820, hiromi.ono@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; 2017
Loan Repayment.
Date: March 26, 2017.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Lyle Furr, Scientific
Review Officer, Office of Extramural Policy
and Review, National Institute on Drug
Abuse, NIH, DHHS, Room 4227, MSC 9550,
6001 Executive Boulevard, Bethesda, MD
20892–9550, 301–827–5702, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: March 7, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–04808 Filed 3–10–17; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
13461
ADVISORY COUNCIL ON HISTORIC
PRESERVATION
Notice of Advisory Council on Historic
Preservation Quarterly Business
Meeting
Advisory Council on Historic
Preservation.
ACTION: Notice of Advisory Council on
Historic Preservation Quarterly Business
Meeting.
AGENCY:
Notice is hereby given that
the Advisory Council on Historic
Preservation (ACHP) will hold its next
quarterly meeting on Thursday, March
23, 2017. The meeting will be held in
Room SR325 at the Russell Senate
Office Building at Constitution and
Delaware Avenues NE., Washington,
DC, starting at 8:30 a.m. EST.
DATES: The quarterly meeting will take
place on Thursday, March 23, 2017,
starting at 8:30 a.m.
ADDRESSES: The meeting will be held in
Room SR325 at the Russell Senate
Office Building at Constitution and
Delaware Avenues NE., Washington,
DC.
FOR FURTHER INFORMATION CONTACT:
Cindy Bienvenue, 202–517–0202,
cbienvenue@achp.gov.
SUPPLEMENTARY INFORMATION: The
Advisory Council on Historic
Preservation (ACHP) is an independent
federal agency that promotes the
preservation, enhancement, and
sustainable use of our nation’s diverse
historic resources, and advises the
President and the Congress on national
historic preservation policy. The goal of
the National Historic Preservation Act
(NHPA), which established the ACHP in
1966, is to have federal agencies act as
responsible stewards of our nation’s
resources when their actions affect
historic properties. The ACHP is the
only entity with the legal responsibility
to encourage federal agencies to factor
historic preservation into their decision
making. For more information on the
ACHP, please visit our Web site at
www.achp.gov.
The agenda for the upcoming
quarterly meeting of the ACHP is the
following:
SUMMARY:
I. Chairman’s Welcome
II. Swearing-In Ceremony
III. Transitions
A. The New Administration
B. ACHP Transition to Full-Time Chairman
1. Operating Procedures Amendments
2. Further Organizational Issues
IV. Section 106 Issues
A. Infrastructure Projects and Tribal
Consultation Issues
B. Administration Infrastructure Initiative
C. Program Alternatives Under
Development
E:\FR\FM\13MRN1.SGM
13MRN1
Agencies
[Federal Register Volume 82, Number 47 (Monday, March 13, 2017)]
[Notices]
[Page 13461]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-04808]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Nicotinic Immune Modulation in the Presence of HIV-1
Infection (R01).
Date: March 22, 2017.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Shang-Yi Anne Tsai, Ph.D., Scientific Review
Officer, Office of Extramural Policy and Review, Division of
Extramural Research, National Institute on Drug Abuse, NIH, DHHS,
6001 Executive Boulevard, Room 4228, MSC 9550, Bethesda, MD 20892,
301-827-5842, shangyi.tsai@nih.gov.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; HIV, HCV and Related Comorbidities in Rural
Communities Affected by Opioid Injection Drug Epidemics in the
United States: Building Systems for Prevention, Treatment and
Control (UG3/UH3).
Date: March 24, 2017.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate cooperative agreement
applications.
Place: Courtyard by Marriott Chevy Chase, 5520 Wisconsin Avenue,
Chevy Chase, MD 20815.
Contact Person: Hiromi Ono, Ph.D., Scientific Review Officer,
Office of Extramural Policy and Review, National Institute on Drug
Abuse, National Institutes of Health, DHHS, 6001 Executive
Boulevard, Room 4238, MSC 9550, Bethesda, MD 20892, 301-827-5820,
hiromi.ono@nih.gov.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Hepatitis C Virus (HCV) Advanced Molecular Detection
in Support of Systems for Prevention, Treatment and Control of HIV,
HCV and Related Comorbidities in Rural Communities Affected by
Opioid Injection Drug Epidemics in the Unite.
Date: March 24, 2017.
Time: 12:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate cooperative agreement
applications.
Place: Courtyard by Marriott Chevy Chase, 5520 Wisconsin Avenue,
Chevy Chase, MD 20815.
Contact Person: Hiromi Ono, Ph.D., Scientific Review Officer,
Office of Extramural Policy and Review, National Institute on Drug
Abuse, National Institutes of Health, DHHS, 6001 Executive
Boulevard, Room 4238, MSC 9550, Bethesda, MD 20892, 301-827-5820,
hiromi.ono@nih.gov.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; 2017 Loan Repayment.
Date: March 26, 2017.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
Contact Person: Lyle Furr, Scientific Review Officer, Office of
Extramural Policy and Review, National Institute on Drug Abuse, NIH,
DHHS, Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD
20892-9550, 301-827-5702, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug
Abuse and Addiction Research Programs, National Institutes of
Health, HHS)
Dated: March 7, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-04808 Filed 3-10-17; 8:45 am]
BILLING CODE 4140-01-P